Patent Law Weblog
recent posts
- USPTO Moves to Protect Design Rights for Digital Innovations
- Judicial Conduct and Disability Committee Has Its Say, Denies Judge Newman’s Latest Request for Review
- PTAB Issues Judgment on Priority in CRISPR Interference
- Parties File Supplemental Priority Statements in CRISPR Interference
- Why the Alice Test is Stupid, Part V: The Goalposts Keep Moving
about
Month: November 2011
-
By Sherri Oslick — About Court Report: Each week we will report briefly on recently filed biotech and pharma cases. Cephalon Inc. et al. v. Breckenridge Pharmaceutical Inc. et al.1:11-cv-01070; filed November 2, 2011 in the District Court of Delaware • Plaintiffs: Cephalon Inc.; Cephalon France• Defendants: Breckenridge Pharmaceutical Inc.; Natco Pharma Ltd. Infringement of…
-
November 9, 2011 – Optimizing Relations with the USPTO: All the Questions You Always Wanted to Ask and Could Never Get Answers For (Association of Intellectual Property Firms) – 12:30 – 1:30 pm (EST) November 14, 2011 – Global Perspectives on the Role of Intellectual Property Rights in Innovation and Development (The World Bank) –…
-
The Intellectual Property Law Association of Chicago (IPLAC) Biotech Committee will be offering a seminar on "Recent Developments in Biotech Patent Law Practice" on November 18, 2011 from 11:45 am to 1:30 pm (Central) at the offices of Quarles & Brady in Chicago, IL. The seminar will offer presentations on the following topics: • AIA's…
-
As part of Law, Justice and Development (LJD) Week 2011, which is being co-sponsored by the World Bank's Legal Vice Presidency, International Finance Corporation (IFC), Multilateral Investment Guarantee Agency (MIGA), and International Centre for the Settlement of Investment Disputes (ICSID), the World Bank Group will be hosting a presentation and panel discussion on "Global Perspectives…
-
Strafford will be offering a webinar entitled "Biosimilars: Emerging Legal Challenges" on December 6, 2011 from 1:00 – 2:30 PM (EST). Anthony Fitzpatrick of Duane Morris and Daniel Kracov of Arnold & Porter will provide a review of the complex standards of the Biosimilar Approval Pathway and address patent and exclusivity concerns around the development…
-
By Kevin E. Noonan — Sometimes it is what a court doesn't do that points to what needs to be done. That appears to be the case for claim construction and the Federal Circuit's standard, since Cybor Corp. v. FAS Techs., Inc., 138 F.3d 1448 (Fed. Cir. 1998), that the appellate court should review claim…
-
By Donald Zuhn — Last week, the U.S. Patent and Trademark Office announced the establishment of a new Patent Prosecution Highway (PPH) pilot program with the Norwegian Industrial Property Office (NIPO). As with other PPH programs, the USPTO-NIPO PPH will permit an applicant having an application whose claims have been allowed in one of the…
-
By Donald Zuhn — Last week, the World Intellectual Property Organization (WIPO) announced the launch of WIPO Re:Search, a consortium of public and private sector organizations sharing intellectual property (IP) and expertise with the global health research community to promote the development of new drugs, vaccines, and diagnostics for the treatment of neglected tropical diseases,…
Patent Docs 